Search

Author/Creator Curry, Michael P

1. Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals. (18th November 2021)

Authors:
Collier, Ai-ris Y; Yu, Jingyou; McMahan, Katherine; Liu, Jinyan; Atyeo, Caroline; Ansel, Jessica L; Fricker, Zachary P; Pavlakis, Martha; Curry, Michael P; Jacob-Dolan, Catherine; Patel, Het; Sellers, Daniel; Barrett, Julia; Rowe, Marjorie; Ahmad, Kunza; Gompers, Annika; Aguayo, Ricardo; Chandras...
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 7(2022)
Page Start:
1124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. (August 2018)

Authors:
Bourlière, Marc; Gordon, Stuart C; Schiff, Eugene R; Tran, Tram T; Ravendhran, Natarajan; Landis, Charles S; Hyland, Robert H; Stamm, Luisa M; Zhang, Jie; Dvory-Sobol, Hadas; Subramanian, G Mani; Brainard, Diana M; McHutchison, John G; Serfaty, Lawrence; Thompson, Alex J; Sepe, Thomas E; Curry, M...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 3:Number 8(2018)
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta-analysis. (June 2019)

Authors:
Cornberg, Markus; Negro, Francesco; Lampertico, Pietro; Turnes, Juan; Curry, Michael P; Brown, Ashley; Wedemeyer, Heiner; Carrion, Jose A; Wick, Nicole; Pangerl, Andreas
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A147
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. (October 2016)

Authors:
Younossi, Zobair M; Stepanova, Maria; Charlton, Michael; Curry, Michael P; O'Leary, Jacqueline G; Brown, Robert S; Hunt, Sharon
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 1:Number 2(2016)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗